The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells

被引:14
|
作者
Chen, Lei [1 ]
Lagunoff, Michael [1 ]
机构
[1] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
关键词
KSHV; interleukin; 6; IL-6; vIL-6; Kaposi's sarcoma;
D O I
10.1016/j.virol.2006.09.044
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Kaposi's Sarcoma-associated herpesvirus encodes a homolog of the human cellular interleukin-6 that may play a formative role in many KSHV-related diseases. While the viral IL-6 can signal similarly to its human counterpart little is known about the role of vIL-6 during KSHV infection. Using homologous recombination and selection in eukaryotic cells, a KSHV isolate was purified that does not express vIL-6 as was a control recombinant that left vIL-6 intact. The two viruses establish and maintain latency to similar levels in BJAB B-cells, reactivate to similar levels in B-cells and Monkey kidney cells and have very similar KSHV gene expression patterns. BJAB cells expressing KSHV survive better than the parental BJAB cells in low serum and the vIL-6 deletion does not abrogate this growth advantage. Thus vIL-6 is not essential for establishment, maintenance, or reactivation from latency in cell culture and is not involved in the survival of infected BJAB B-cells in low serum. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:425 / 435
页数:11
相关论文
共 50 条
  • [1] KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
    Coen, Natacha
    Duraffour, Sophie
    Snoeck, Robert
    Andrei, Graciela
    VIRUSES-BASEL, 2014, 6 (11): : 4731 - 4759
  • [2] Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages
    Shimoda, Michiko
    Inagaki, Tomoki
    Davis, Ryan R.
    Merleev, Alexander
    Tepper, Clifford G.
    Maverakis, Emanual
    Izumiya, Yoshihiro
    PLOS PATHOGENS, 2023, 19 (10)
  • [3] K13 Blocks KSHV Lytic Replication and Deregulates vIL6 and hIL6 Expression: A Model of Lytic Replication Induced Clonal Selection in Viral Oncogenesis
    Zhao, Jinshun
    Punj, Vasu
    Matta, Hittu
    Mazzacurati, Lucia
    Schamus, Sandra
    Yang, Yanqiang
    Yang, Tianbing
    Hong, Yan
    Chaudhary, Preet M.
    PLOS ONE, 2007, 2 (10):
  • [4] Unraveling the Kaposi Sarcoma-Associated Herpesvirus (KSHV) Lifecycle: An Overview of Latency, Lytic Replication, and KSHV-Associated Diseases
    Losay, Victor A.
    Damania, Blossom
    VIRUSES-BASEL, 2025, 17 (02):
  • [5] Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis
    Grundhoff, A
    Ganem, D
    JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (01): : 124 - 136
  • [6] Male hormones transactivate viral noncoding RNA PAN to promote KSHV lytic replication.
    Ding, Mingzhu
    Zhang, Yuqi
    Zheng, Haixiang
    Sun, Rui
    Bai, Lei
    Lan, Ke
    Wang, Xing
    CANCER RESEARCH, 2020, 80 (08) : 38 - 39
  • [7] RUNX3 inhibits KSHV lytic replication by binding to the viral genome and repressing transcription
    Ren, Pengyu
    Niu, Danping
    Chang, Sijia
    Yu, Lei
    Ren, Junrui
    Ma, Yuanming
    Lan, Ke
    JOURNAL OF VIROLOGY, 2024, 98 (02)
  • [8] SERUM INTERLEUKIN-6 IN ESSENTIAL THROMBOCYTHEMIA
    RICERCA, BM
    ROCCA, B
    DELLAVENTURA, M
    STORTI, S
    LANDOLFI, R
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1289 - 1289
  • [9] KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions
    El-Mallawany, Nader Kim
    Mehta, Parth S.
    Kamiyango, William
    Villiera, Jimmy
    Peckham-Gregory, Erin C.
    Kampani, Coxcilly
    Krysiak, Robert
    Sanders, Marcia K.
    Caro-Vegas, Carolina
    Eason, Anthony B.
    Ahmed, Saeed
    Schutze, Gordon E.
    Martin, Stephen C.
    Kazembe, Peter N.
    Scheurer, Michael E.
    Dittmer, Dirk P.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (01) : 110 - 116
  • [10] Modification of viral myocarditis in mice by interleukin-6
    Kanda, T
    McManus, JEW
    Nagai, R
    Imai, S
    Suzuki, T
    Yang, DC
    McManus, BM
    Kobayashi, I
    CIRCULATION RESEARCH, 1996, 78 (05) : 848 - 856